Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1969-9-30
|
| pubmed:language |
rum
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0048-7848
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
73
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
445-53
|
| pubmed:dateRevised |
2011-1-13
|
| pubmed:meshHeading |
pubmed-meshheading:5801982-Adolescent,
pubmed-meshheading:5801982-Anabolic Agents,
pubmed-meshheading:5801982-Anemia, Aplastic,
pubmed-meshheading:5801982-Child,
pubmed-meshheading:5801982-Chloramphenicol,
pubmed-meshheading:5801982-Female,
pubmed-meshheading:5801982-Hemorrhagic Disorders,
pubmed-meshheading:5801982-Humans,
pubmed-meshheading:5801982-Male,
pubmed-meshheading:5801982-Nandrolone,
pubmed-meshheading:5801982-Piperazines
|
| pubmed:articleTitle |
[Contributions to the treatment of pancytopenia].
|
| pubmed:publicationType |
Journal Article
|